CR6261

CR6261
[[File:|frameless|220px|alt=|]]
INN
Drug class
Routes of administration
Pregnancy category	N/A
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status	Investigational (animal studies)
CAS Number
PubChem
DrugBank
ChemSpider	none
KEGG

CR6261 is a monoclonal antibody<ref>,

 New Class of Monoclonal Antibodies against Severe Influenza: Prophylactic and Therapeutic Efficacy in Ferrets, 
 PLoS ONE, 
 2010,
 Vol. 5(Issue: 2),
 pp. e9106,
 DOI: 10.1371/journal.pone.0009106,
 PMID: 20161706,
 PMC: 2817000,</ref> that binds to a broad range of the influenza virus including the 1918 "Spanish flu" (SC1918/H1) and to a virus of the H5N1 class of avian influenza that jumped from chickens to a human in Vietnam in 2004 (Viet04/H5). In contrast to most antibodies generated by exposure to influenza, which can only neutralize a few strains from within a single virus subtype, CR6261 neutralizes numerous strains from multiple subtypes.  CR6261 recognizes a highly conserved helical region in the membrane-proximal stem of hemagglutinin, the predominant protein on the surface of the influenza virus.  Based upon the conservation of the amino acid sequence on this part of hemagglutinin, CR6261 is predicted to neutralize roughly 50% of all flu viruses.  It was found by The Scripps Research Institute and the Dutch biopharmaceutical company, Crucell.

See also

• Immunology

References

• Research team finds immune molecule that attacks wide range of flu viruses[1]
• Immune Molecule That Attacks Wide Range Of Flu Viruses Discovered[2]
• Antibody Recognition of a Highly Conserved Influenza Virus Epitope[3]

   This article is a monoclonal antibody–related stub. You can help WikiMD by expanding it!

   This article is a antiinfective drug stub. You can help WikiMD by expanding it!

   This article is a medical stub. You can help WikiMD by expanding it!